Caprock Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$2.78M Buy
6,380
+989
+18% +$430K 0.08% 207
2024
Q4
$1.99M Buy
+5,391
New +$1.99M 0.07% 261
2024
Q3
Sell
-6,318
Closed -$3.42M 926
2024
Q2
$3.42M Buy
6,318
+2,108
+50% +$1.14M 0.14% 118
2024
Q1
$2.18M Sell
4,210
-150
-3% -$77.8K 0.13% 116
2023
Q4
$2.06M Sell
4,360
-39
-0.9% -$18.4K 0.13% 126
2023
Q3
$1.92M Buy
4,399
+65
+1% +$28.3K 0.14% 107
2023
Q2
$1.93M Sell
4,334
-24
-0.6% -$10.7K 0.14% 113
2023
Q1
$2M Buy
4,358
+284
+7% +$131K 0.16% 106
2022
Q4
$2.09M Buy
4,074
+225
+6% +$115K 0.19% 81
2022
Q3
$1.75M Buy
3,849
+114
+3% +$51.8K 0.17% 83
2022
Q2
$1.8M Buy
3,735
+233
+7% +$112K 0.18% 84
2022
Q1
$1.72M Buy
3,502
+451
+15% +$222K 0.16% 105
2021
Q4
$1.41M Buy
3,051
+255
+9% +$118K 0.12% 129
2021
Q3
$1.04M Buy
2,796
+41
+1% +$15.3K 0.09% 149
2021
Q2
$1.05M Buy
2,755
+14
+0.5% +$5.35K 0.1% 157
2021
Q1
$984K Sell
2,741
-499
-15% -$179K 0.11% 146
2020
Q4
$1.04M Sell
3,240
-173
-5% -$55.5K 0.12% 137
2020
Q3
$917K Buy
3,413
+254
+8% +$68.2K 0.13% 127
2020
Q2
$831K Buy
3,159
+363
+13% +$95.5K 0.12% 134
2020
Q1
$635K Buy
2,796
+80
+3% +$18.2K 0.12% 129
2019
Q4
$820K Buy
2,716
+353
+15% +$107K 0.15% 115
2019
Q3
$567K Buy
2,363
+193
+9% +$46.3K 0.11% 140
2019
Q2
$612K Sell
2,170
-179
-8% -$50.5K 0.12% 142
2019
Q1
$674K Sell
2,349
-394
-14% -$113K 0.13% 138
2018
Q4
$720K Buy
2,743
+141
+5% +$37K 0.17% 115
2018
Q3
$713K Sell
2,602
-2
-0.1% -$548 0.15% 128
2018
Q2
$620K Sell
2,604
-25
-1% -$5.95K 0.13% 144
2018
Q1
$578K Sell
2,629
-1
-0% -$220 0.12% 156
2017
Q4
$631K Buy
2,630
+20
+0.8% +$4.8K 0.12% 165
2017
Q3
$496K Sell
2,610
-100
-4% -$19K 0.1% 189
2017
Q2
$510K Buy
2,710
+130
+5% +$24.5K 0.11% 170
2017
Q1
$427K Sell
2,580
-136
-5% -$22.5K 0.1% 181
2016
Q4
$390K Sell
2,716
-496
-15% -$71.2K 0.1% 185
2016
Q3
$402K Buy
+3,212
New +$402K 0.09% 209